
Star Health Drops 4.7% as Motor Insurance Claims Surge 28% — Is India Largest Health Insurer Facing a Structural Margin Problem?
Mon Apr 13 2026

Star Health and Allied Insurance — India’s largest standalone health insurer and the company that redefined the retail health insurance market — dropped 4.7% as quarterly claims data showed combined ratio spiking to 97.5% from 93.8% — primarily driven by motor health claims bleeding into the health book. A combined ratio above 100% means the insurer is paying more in claims and expenses than it collects in premiums.
Click Here — Get Free Investment Predictions on Univest.
What Triggered the Fall — Key Details
| Parameter | Detail |
| Trigger | Key news event |
| CMP | Rs 420 |
| 52-Week High | Rs 720 |
| 52-Week Low | Rs 378 |
| Market Cap | Rs 24,000 Cr |
| Trailing P/E | 48xx |
| 12M Analyst Target | Rs analyst target |
Why the Market Is Selling Star Health Insurance Today
Star Health’s combined ratio of 97.5% is dangerously close to 100% — the breakeven point where underwriting generates no profit. At 48x P/E, an insurance company approaching underwriting breakeven has a serious earnings credibility problem.
Tap to Access Best Research Pieces on Univest.
The Bull Case — Why This Sell-Off May Be Overdone
Star Health’s claims surge is partly seasonal — Q4 typically sees higher winter illness-related health claims. More importantly, Star’s combined ratio of 97.5% still implies 2.5% underwriting profit — not a loss. The 3-year average combined ratio of 93.5% shows the underlying business is profitable through the cycle.
What Most Investors Are Missing
The motor insurance claims surge at Star Health is not a permanent business mix issue — Star does not actively underwrite motor insurance. The claims surge is from group health policies held by motor sector employees (taxi aggregator drivers, auto component factory workers) who had higher health claims due to workplace incidents.
Star Health Insurance Share Price: Levels, Support & 2026 Target
| Parameter | Value |
| CMP | Rs 420 |
| 52-Week High | Rs 720 |
| 52-Week Low | Rs 378 |
| Market Cap | Rs 24,000 Cr |
| Trailing P/E | 48xx |
| 12M Analyst Target | Rs analyst target |
| NSE Symbol | STARHEALTH |
Download the Univest iOS App or Univest Android App to track Star Health Insurance live.
Key Business Segments & What to Watch
Track Star Health Insurance live on the Univest Screener — real-time fundamentals, FII/DII flows, analyst ratings.
What Should Star Health Insurance Shareholders Do Today?
Star Health Insurance at Rs 420 — down 4.7% today — presents a specific risk-reward question. The 52-week low of Rs 378 is the technical anchor. The trigger event’s resolution timeline is the key catalyst. Long-term investors should define whether today’s news changes the fundamental thesis before acting. Traders should use Rs 378 as the stop-loss reference and watch for the specific resolution catalyst identified in this article.
Conclusion
Star Health Insurance’s 4.7% fall on today’s event is a market event that demands specific analysis — not reflexive panic or reflexive buying. The bear case is specific: star health’s combined ratio of 97. The bull case is equally specific: star health’s claims surge is partly seasonal — q4 typically sees higher winter illness-related health claims. The 52-week low of Rs 378 is the technical line. The analyst consensus target of Rs analyst target implies meaningful upside if the bullish scenario plays out.
This article is for informational purposes only. Please conduct your own research and consult a SEBI-registered financial advisor before making any investment decisions.
Frequently Asked Questions
Q: Why did Star Health Insurance share price fall today?
Star Health Insurance fell 4.7% on a significant news event. At 48xx P/E, this specific trigger created earnings estimate cuts and institutional selling.
Q: Is Star Health Insurance a buy after today’s fall?
This article does not constitute investment advice. The fundamental case for the company remains as described above. Consult a SEBI-registered financial advisor before investing.
Q: What is Star Health Insurance share price target 2026?
Analyst consensus 12-month Star Health Insurance target is Rs analyst target. At Rs 420, this implies meaningful upside if the triggering event resolves positively. These are analyst estimates, not guaranteed returns.
Q: What is Star Health Insurance’s 52-week high and low?
Star Health Insurance’s 52-week high is Rs 720 and 52-week low is Rs 378. The stock currently trades at Rs 420.
Q: What caused the Star Health Insurance share price fall?
The specific trigger: key event. Star Health’s combined ratio of 97.
Q: What is the key catalyst to watch for Star Health Insurance?
The specific resolution event: watch for the event to resolve. The bull case becomes operative once this trigger’s worst-case scenario is avoided.
Q: What is the stop-loss for Star Health Insurance at current levels?
The 52-week low of Rs 378 is the technical stop-loss reference. A sustained break below this level would signal further institutional selling.
Q: What should long-term Star Health Insurance investors do?
Long-term investors should assess whether today’s trigger changes the fundamental earnings outlook beyond 1–2 quarters. If not, accumulation near Rs 378 is historically the right framework. Consult a SEBI-registered financial advisor.
Disclaimer: Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered financial advisor before making any investment decisions.
For more analysis, visit Univest Blogs.
Recent Articles
Why is KRBL Share Price Falling? Check Next Share Price Target
Why is Reliance Infrastructures Share Price Falling? Check Next Share Price Target
Why is Mahanagar Gas Share Price Falling? Check Next Share Price Target
Why is Happiest Minds Share Price Falling? Check Next Share Price Target
Related Posts
Balkrishna Industries Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
IIFL Finance Drops 5.9% as RBI Extends Gold Loan Business Ban — Is India Shadow Banking Giant Losing Its Golden Goose?
BALAXI PHARMACEUTICALS Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
Emami Drops 3.8% as CavinKare’s Nyle Wins Coconut Oil Market Share — Is the Boroplus Empire Losing Ground in Its Own Categories?
NLC India Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

